STVN
Stevanato Group SpA
NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$18.28
+0.27% today
Updated 2026-05-11
Market cap
$4.99B
P/E ratio
30.47
P/S ratio
4.15x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$13 – $28
Volume
0.6M
Stevanato Group SpA (STVN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $42.57M | $155.66M | $133.30M | $103.30M | $105.21M | $155.78M | $274.79M |
| Capital expenditures | $73.91M | $96.00M | $113.18M | $243.13M | $441.93M | $313.57M | $253.35M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $2.39M | $-9.09M | $8.10M | $1.98M | — | — |
| Free cash flow | $-31.33M | $59.65M | $20.12M | $-139.83M | $-336.72M | $-157.79M | $21.44M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | $6.17M | $8.90M | $11.20M | $13.50M | $14.29M | $14.46M | $14.16M |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |